アラゴン労働者の健康研究 (AWHS)
Diana María Mérida1,2,3, Carolina Torrijo-Belanche4, Belén Moreno-Franco4,5,6
1Department of Preventive Medicine and Public Health. School of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain.
American journal of preventive cardiology
|August 20, 2025
まとめ
モノエチルフタラート (MEP) への曝露は,男性労働者のサブクリニカル冠動脈硬化症 (SCA) のより高い罹患率に関連しています. MEPの曝露を減らすことは,早期の心血管疾患の予防に役立ちます.
科学分野:
- 環境 健康
- 心血管研究
- 毒理学について
背景:
- 酸化ストレスと内皮機能不全を含む心臓血管疾患のメカニズムと関連している.
- サブクリニカル冠動脈硬化症 (SCA) は,心血管疾患の初期指標である.
- SCAにおけるフタラート曝露の役割の評価は公衆衛生にとって極めて重要です.
研究 の 目的:
- フタラート曝露と亜臨床冠動脈硬化症 (SCA) の関連性を評価する.
- 特定のフタラート代謝物とSCAの流行との相関性を調査する.
主な方法:
- 自動車組立工場の1119人の男性労働者が,尿中のフタラート代謝産物について分析された.
- サブクリニカル冠動脈動脈硬化症 (SCA) は冠動脈カルシウムスコアによって定義された.
- 混同因子に調整されたロジスティック回帰モデルは,関連を決定するために使用されました.
主要な成果:
- 参加者のSCAの罹患率は10. 2%でした.
- モノエチルフタラート (MEP) の濃度は,SCA患者で高かった.
- MEPの曝露の増加は,SCAのより高い罹患率と有意に関連していた (OR: 1.21)
結論:
- モノエチルフタラート (MEP) 曝露は,サブクリニカル冠動脈硬化症 (SCA) の有病率の増加と関連しています.
- これらの発見は,MEPが心血管疾患の早期発症に寄与することを示唆しています.
- 心血管疾患を予防するための戦略として,フタラートへの曝露を減らすことが考えられます.
関連する概念動画
Peripheral Artery Disease I: Introduction
32
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
32
Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Atherosclerosis I: Introduction
74
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
74
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
37
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
37
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32


